Stay updated with breaking news from Variola Virus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Frederick, MD (PRWEB) July 15, 2022 -- BioFactura today announced its second contract option activation of $15.9 million from the Biomedical Advanced Research
The outbreak of monkeypox infections continues to climb rapidly as health authorities attempt to determine its epidemiologic links to recent festivals. Given the limited nature of the disease and spread the WHO has attempted to downplay the threat it poses.
Smallpox vials were found at a laboratory in the US state of Pennsylvania. Smallpox can be lethal even after it is freeze-dried.
BioFactura Funded $13 Million Contract Option for its Smallpox Biodefense Therapeutic Share Article Confirms BARDA support of critical medical countermeasure development Dr. Darryl Sampey, President and CEO of BioFactura, stated, “Funding of our first option confirms the commitment of BARDA to support development of this important product. We look forward to continuing our close collaboration with BARDA as we move into the pathway to FDA approval." FREDERICK, Md. (PRWEB) February 19, 2021 BioFactura, Inc. today announced a con...